The aim of this study was to measure entrance skin doses on patients undergoing cone-beam computed tomography (CBCT) examinations, to establish conversion factors between skin and organ doses, and to estimate cancer risk from CBCT exposures. 266 patients (age 8-83) were included, involving three imaging centres. CBCT scans were acquired using the SCANORA 3D (Soredex, Tuusula, Finland) and NewTom 9000 (QR, Verona, Italy).
View Article and Find Full Text PDFObjectives: (a) To measure the absorbed radiation doses at 16 anatomical sites of a Rando phantom and (b) to calculate the effective doses including and excluding the salivary gland doses in panoramic radiography using a conventional and a digital panoramic device.
Study Design: Thermoluminescent dosimeters (TLD-100) were placed at 16 sites in a Rando phantom, using a conventional, Planmeca Promax and a digital, Planmeca PM2002CC Proline 2000 (Planmeca Oy, 00880 Helsinki, Finland) panoramic device for panoramic radiography. During conventional radiography the selected exposure settings were 66 kVp, 6 mA and 16s, while during digital radiography two combinations were selected 60 kVp, 4 mA, 18 s and 66 kVp, 8 mA, 18s with and without image processing function.
Objectives: (a) To measure the absorbed dose at certain anatomical sites of a RANDO phantom and to estimate the effective dose in radiographic imaging of the jaws using low dose Cone Beam computed tomography (CBCT) and (b) to compare the absorbed and the effective doses between thyroid and cervical spine shielding and non-shielding techniques.
Study Design: Thermoluminescent dosimeters (TLD-100) were placed at 14 sites in a RANDO phantom, using a Cone Beam CT device (Newtom, Model QR-DVT 9000, Verona, Italy). Dosimetry was carried out applying two techniques: in the first, there was no shielding device used while in the second one, a shielding device (EUREKA!, TRIX) was applied for protection of the thyroid gland and the cervical spine.